A Phase 4 Trial Comparing the Efficacy of Subcutaneous Injections of Brodalumab to Oral Administrations of Fumaric Acid Esters in Adults With Moderate to Severe Plaque Psoriasis
Phase of Trial: Phase IV
Latest Information Update: 21 Aug 2019
Price : $35 *
At a glance
- Drugs Brodalumab (Primary) ; Fumaric acid
- Indications Plaque psoriasis
- Focus Therapeutic Use
- Sponsors LEO Pharma
- 28 Mar 2019 Status changed from recruiting to completed.
- 19 Dec 2018 Planned End Date changed from 1 Oct 2018 to 1 May 2019.
- 19 Dec 2018 Planned primary completion date changed from 1 May 2018 to 1 Mar 2019.